Medicare Enrolled

Dr. Takahiro Otsuka, MD

Endocrinology · Loma Linda, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11370 ANDERSON ST, Loma Linda, CA 92354
9095582870
In practice since 2006 (19 years)
NPI: 1790895803 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Otsuka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Otsuka? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Otsuka

Dr. Takahiro Otsuka is an endocrinology specialist in Loma Linda, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Otsuka performed 1,146 Medicare services across 582 unique beneficiaries.

Between the years covered by Open Payments, Dr. Otsuka received a total of $9,932 from 42 pharmaceutical and/or device companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Otsuka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 40% volume in CA $9,932 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,146
Medicare services
Top 40% in CA for endocrinology
582
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~60 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
395 $64 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
374 $97 $226
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
98 $27 $85
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
86 $60 $180
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
65 $105 $375
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
43 $141 $445
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
32 $127 $267
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
29 $135 $262
Telehealth originating site facility fee
A fee charged by the facility where a patient is located for telehealth services. This covers the use of the site's equipment and staff to connect with a remote provider.
13 $17 $50
New patient office visit, complex (60-74 min) 11 $180 $325
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,932
Total received (2018-2024)
Avg $1,419/year across 7 years
Top 20% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
635
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,893 (99.6%)
Other
Charitable contributions, space rental, and other categories
$38 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,374
2023
$2,044
2022
$1,562
2021
$1,221
2020
$817
2019
$1,459
2018
$1,454

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$231
Bayer Healthcare Pharmaceuticals Inc.
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$160
Abbott Laboratories
$149
Xeris Pharmaceuticals, Inc.
$148
Corcept Therapeutics
$95
Mannkind Corporation
$89
Novartis Pharmaceuticals Corporation
$70
Amgen Inc.
$45
Ascendis Pharma Inc
$40
Neurocrine Biosciences, Inc.
$32
Kyowa Kirin, Inc.
$29
Alexion Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme LLC
$25
Lilly USA, LLC
$22
Dexcom, Inc.
$16
Tandem Diabetes Care, Inc.
$16
Insulet Corporation
$14
Top 3 companies account for 40.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,925
Abbott Laboratories
$1,246
MannKind Corporation
$636
Boehringer Ingelheim Pharmaceuticals, Inc.
$615
Dexcom, Inc.
$587
SANOFI-AVENTIS U.S. LLC
$563
Corcept Therapeutics
$475
Mannkind Corporation
$380
Bayer Healthcare Pharmaceuticals Inc.
$324
Bayer HealthCare Pharmaceuticals Inc.
$307
Xeris Pharmaceuticals, Inc.
$224
Medtronic, Inc.
$202
Lilly USA, LLC
$202
AstraZeneca Pharmaceuticals LP
$202
Horizon Therapeutics plc
$174
Merck Sharp & Dohme Corporation
$170
Insulet Corporation
$159
Amgen Inc.
$156
DEXCOM, INC.
$150
Esperion Therapeutics, Inc.
$109
Novartis Pharmaceuticals Corporation
$108
Janssen Pharmaceuticals, Inc
$106
LifeScan, Inc.
$102
Amarin Pharma Inc.
$98
Medtronic MiniMed, Inc.
$98
Radius Health, Inc.
$79
Kyowa Kirin, Inc.
$66
Shionogi Inc
$58
Shire North American Group Inc
$54
Amryt Pharma Holdings Ltd
$42
Ascendis Pharma Inc
$40
CeQur Corporation
$39
Baxter Healthcare
$38
Ultragenyx Pharmaceutical Inc.
$33
Neurocrine Biosciences, Inc.
$32
Alexion Pharmaceuticals, Inc.
$25
Merck Sharp & Dohme LLC
$25
Biohaven Pharmaceuticals, Inc.
$20
Smith+Nephew, Inc.
$18
Tandem Diabetes Care, Inc.
$16
ABBVIE INC.
$15
Acerus Pharmaceuticals Corporation
$13
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BELSOMRA · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fetroja · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LYUMJEV · Levemir · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NEXLETOL · NURTEC ODT · Natesto · OT Verio Flex Starter Kit · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch Verio Reflect · Ozempic · PIFELTRO · PRALUENT · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · STRENSIQ · Santyl · Saxenda · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · Vascepa · Victoza · XARELTO · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Loma Linda?
Compare endocrinologists in the Loma Linda area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
32
Per 100K population
1.5
County median income
$82,184
Nearest hospital
LOMA LINDA UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Otsuka is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Otsuka experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Otsuka performed 395 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Otsuka receive payments from pharmaceutical companies?
Yes. Dr. Otsuka received a total of $9,932 from 42 companies across 635 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Otsuka's costs compare to other endocrinologists in Loma Linda?
Dr. Otsuka's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Otsuka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →